المؤلفون: E. I. Kasikhina, A. Ya. Nada, O. V. Zhukova, M. N. Ostretsova, Е. И. Касихина, А. Я. Нада, О. В. Жукова, М. Н. Острецова

المصدر: Meditsinskiy sovet = Medical Council; № 15 (2024); 224–230 ; Медицинский Совет; № 15 (2024); 224–230 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: желудочно-кишечные медиаторные симптомы, indolent systemic mastocytosis, children, tryptase, hystamin, gastrointestinal symptoms, дети, триптаза, гистамин

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/8591/7546; Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200–1228. https://doi.org/10.1182/blood.2022015850.; Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36(7):1703–1719. https://doi.org/10.1038/s41375-022-01613-1.; Jackson CW, Pratt CM, Rupprecht CP, Pattanaik D, Krishnaswamy G. Mastocytosis and Mast Cell Activation Disorders: Clearing the Air. Int J Mol Sci. 2021;22(20):11270. https://doi.org/10.3390/ijms222011270.; Lange M, Hartmann K, Carter MC, Siebenhaar F, Alvarez-Twose I, Torrado I et al. Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021. Int J Mol Sci. 2021;22(5):2586. https://doi.org/10.3390/ijms22052586.; Касихина ЕИ, Потекаев НН, Иванова МА, Жукова ОВ, Новожилова ОЛ, Острецова МН, Окенаева А. Клинико-эпидемиологические характеристики кожного мастоцитоза среди детского населения города Москвы. Российский аллергологический журнал. 2024;21(1):74–81. https://doi.org/10.36691/RJA16906.; Vakirlis E, Theodosiou G, Apalla Z, Arabatzis M, Lazaridou E, Sotiriou E et al. A retrospective epidemiological study of skin diseases among pediatric population attending a tertiary dermatology referral center in Northern Greece. Clin Cosmet Investig Dermatol. 2017;10:99–104. https://doi.org/10.2147/CCID.S130126.; Касихина ЕИ, Потекаев НН, Кочетков МА, Жукова ОВ, Острецова МН, Медникова МА, Богдель АМ. Мастоцитоз: ретроспективный анализ пятнистопапулезной кожной формы. Медицинский совет. 2023;17(6):180–185. https://doi.org/10.21518/ms2022-005.; Rastogi V, Singh D, Mazza JJ, Parajuli D, Yale SH. Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila. Clin Med Res. 2018;16(1-2):16–28. https://doi.org/10.3121/cmr.2017.1379a.; Brockow K, Bent RK, Schneider S, Spies S, Kranen K, Hindelang B et al. Challenges in the Diagnosis of Cutaneous Mastocytosis. Diagnostics (Basel). 2024;14(2):161. https://doi.org/10.3390/diagnostics14020161.; Gilreath JA, Tchertanov L, Deininger MW. Novel approaches to treating advanced systemic mastocytosis. Clin Pharmacol. 2019;11:77–92. https://doi.org/10.2147/CPAA.S206615.; Hermine O, Lortholary O, Leventhal PS, Catteau A, Soppelsa F, Baude C et al. Case-control cohort study of patients’ perceptions of disability in mastocytosis. PLoS ONE. 2008;3(5):e2266. https://doi.org/10.1371/journal.pone.0002266.; Brockow K, Plata-Nazar K, Lange M, Nedoszytko B, Niedoszytko M, Valent P. Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis. Int J Mol Sci. 2021;22(5):2684. https://doi.org/10.3390/ijms22052684.; Barnes M, Van L, DeLong L, Lawley LP. Severity of cutaneous findings predict the presence of systemic symptoms in pediatric maculopapular cutaneous mastocytosis. Pediatr Dermatol. 2014;31(3):271–275. https://doi.org/10.1111/pde.12291.; Alvarez-Twose I, Vañó-Galván S, Sánchez-Muñoz L, Morgado JM, Matito A, Torrelo A et al. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy. 2012;67(6):813–821. https://doi.org/10.1111/j.1398-9995.2012.02812.x.; Lange M, Niedoszytko M, Renke J, Gleń J, Nedoszytko B. Clinical aspects of paediatric mastocytosis: a review of 101 cases. J Eur Acad Dermatol Venereol. 2013;27(1):97–102. https://doi.org/10.1111/j.1468-3083.2011.04365.x.; Broesby-Olsen S, Carter M, Kjaer HF, Mortz CG, Møller MB, Kristensen TK et al. Pediatric Expression of Mast Cell Activation Disorders. Immunol Allergy Clin North Am. 2018;38(3):365–377. https://doi.org/10.1016/j.iac.2018.04.009.; Sandow L, Town A, Heinrich MC. Avapritinib treatment of aggressive systemic mastocytosis with a novel KIT exon 17 mutation. Leuk Res Rep. 2023;21:100409. https://doi.org/10.1016/j.lrr.2023.100409.; Caughey GH. Tryptase genetics and anaphylaxis. J Allergy Clin Immunol. 2006;117(6):1411–1114. https://doi.org/10.1016/j.jaci.2006.02.026.; Scudamore CL, Thornton EM, McMillan L, Newlands GF, Miller HR. Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum. J Exp Med. 1995;182(6):1871–1881. https://doi.org/10.1084/jem.182.6.1871.; Gülen T, Hägglund H, Dahlén B, Nilsson G. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease. J Intern Med. 2016;279(3):211–228. https://doi.org/10.1111/joim.12410.; Parente R, Giudice V, Cardamone C, Serio B, Selleri C, Triggiani M. Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation. Int J Mol Sci. 2023;24(8):7071. https://doi.org/10.3390/ijms24087071.; Butterfield JH, Ravi A, Pongdee T. Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis. Immunol Allergy Clin North Am. 2018;38(3):397–410. https://doi.org/10.1016/j.iac.2018.04.011.; Sperr WR, Stehberger B, Wimazal F, Baghestanian M, Schwartz LB, Kundi M et al. Serum tryptase measurements in patients with myelodysplastic syndromes. Leuk Lymphoma. 2002;43(5):1097–1105. https://doi.org/10.1080/10428190290021470.; Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein D, Bernstein J et al. Anaphylaxis-a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341–384. https://doi.org/10.1016/j.anai.2015.07.019.; van Anrooij B, Kluin-Nelemans JC, Safy M, Flokstra-de Blok BM, Oude Elberink JN. Patient-reported disease-specific quality-of-life and symptom severity in systemic mastocytosis. Allergy. 2016;71(11):1585–1593. https://doi.org/10.1111/all.12920.; Никитин СС, Гусева НБ, Карцева АА, Леухин МВ, Леписева ИВ. Современный взгляд на дифференциальную диагностику ультразвуковых характеристик лимфатических узлов при мезадените у детей. Медицинский совет. 2023;17(17):231–237. https://doi.org/10.21518/ms2023-269.

الاتاحة: https://www.med-sovet.pro/jour/article/view/8591
https://doi.org/10.21518/ms2024-415